Stocks and Investing Stocks and Investing
Thu, February 1, 2024

Jessica Fung Maintained (ALNY) at Hold with Increased Target to $170 on, Feb 1st, 2024


Published on 2024-10-28 08:41:33 - WOPRAI, Jessica Fung
  Print publication without navigation


Jessica Fung of JP Morgan, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $150 to $170 on, Feb 1st, 2024.

Jessica has made no other calls on ALNY in the last 4 months.



There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 4 agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $165 on, Monday, January 22nd, 2024
  • Tiago Fauth of "Wells Fargo" Initiated at Hold and Held Target at $171 on, Friday, December 8th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $183 on, Friday, November 3rd, 2023
  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, October 11th, 2023


These are the ratings of the 6 analyists that currently disagree with Jessica


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $395 on, Friday, December 15th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $217 on, Thursday, December 14th, 2023
  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $230 on, Friday, November 3rd, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023

Contributing Sources